ArticleBMC veterinary research2026
Ménétrier-like disease in a dog without glandular atrophy: expanding the morphologic spectrum.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMénétrier’s disease is a rare protein-losing gastropathy characterized by markedly enlarged gastric folds, excessive mucus secretion, and hypoalbuminemia. Histologically, it features pronounced foveolar hyperplasia, cystic dilation of gastric glands, and loss of parietal and chief cells. Although first described in humans, a small number of comparable cases have been reported in dogs, where the condition is referred to as Ménétrier-like disease. In veterinary medicine, this disorder remains poorly defined and appears to be uncommon. CASE PRESENTATION: A 6-year-old intact male French Bulldog was referred for a severe progressive weight loss and acute onset anorexia. Clinical and laboratory findings were suggestive of a protein-losing enteropathy. Abdominal ultrasonography revealed marked thickening of the gastric and small intestinal walls. Gastroscopy showed severe, non-reducible hypertrophy of the gastric folds involving both the fundus and body of stomach. Endoscopic biopsies revealed marked foveolar hyperplasia and cystic glandular dilation without evidence of glandular atrophy. Ménétrier-like hypertrophic gastropathy was considered the most likely diagnosis. Given that the owner declined gastrectomy and treatment with somatostatin analogues for financial constraints, medical management with glucocorticoids and H₂-receptor antagonists was administered. After 10 days, the clinical condition progressively worsened, with the onset of new and evolving neurological deficits. The dog subsequently developed severe neurological signs, and euthanasia was ultimately elected. Histopathological examination of a full-thickness gastric sample confirmed mucosal hypertrophy characterized by branching foveolar hyperplasia and cystic dilation of the glands, again without evidence of parietal cell loss.
conclusionsThis case suggests that canine Ménétrier-like disease may occur even in the absence of glandular atrophy, thereby broadening the currently recognized histologic spectrum of the condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.